13 Best Short Squeeze Stocks to Invest In

Page 5 of 5

6. Summit Therapeutics Inc. (NASDAQ:SMMT)

Summit Therapeutics Inc. (NASDAQ:SMMT) ranks among the best short squeeze stocks to invest in. On May 22, Cantor Fitzgerald restated its Overweight rating for Summit Therapeutics Inc. (NASDAQ:SMMT). The firm addressed concerns about the HARMONi-3 trial, which is evaluating ivonescimab in first-line squamous non-small cell lung cancer.

The trial failed to meet an interim progression-free survival threshold, increasing investor doubts regarding its efficacy in comparison to data from HARMONi-6, a China-exclusive trial.

Cantor Fitzgerald reported that medical professionals were less deterred by the interim progression-free survival shortfall. The expert opinion was influenced by the firm’s low alpha spend and the fact that the analysis was performed very early.

Meanwhile, H.C. Wainwright downgraded Summit Therapeutics Inc. (NASDAQ:SMMT) to Neutral from Buy, noting competition from Merck’s sacituzumab tirumotecan results. The firm stated that sacituzumab tirumotecan, coupled with pembrolizumab, had an immature overall survival hazard ratio of 0.55, which might place strain on Summit’s ivonescimab if the trend continues with prolonged follow-up.

Summit Therapeutics Inc. (NASDAQ:SMMT) is a biopharmaceutical firm. The company’s main product, Ridinilazole, is an orally administered small-molecule antibiotic now in Phase III clinical trials to treat CDI.

While we acknowledge the potential of SMMT to grow, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and have limited downside risk. If you are looking for an AI stock that is more promising than SMMT and that has 100x upside potential, check out our report about the cheapest AI stock.

Click to continue reading and see the 5 Best Short Squeeze Stocks to Invest In.

Disclosure: None. Follow Insider Monkey on Google News.

Page 5 of 5
1281292 - 11759070 - 1